Covered recipient · General Payments record
PHILIP H WASSERSTEIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,964.13
- Reported across 135 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $767.89 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $400.43 | 18 |
| UCB, Inc. | $102.14 | 3 |
| Neurocrine BioSciences, Inc. | $73.59 | 2 |
| Teva Pharmaceuticals USA, Inc. | $29.50 | 1 |
| Acorda Therapeutics, Inc | $28.34 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.05 | 1 |
| Sumitomo Pharma America, Inc. | $23.91 | 1 |
| Amgen Inc. | $22.91 | 1 |
| BANNER LIFE SCIENCES, LLC | $22.22 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.26 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.97 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311801 | CMS |
| ABBVIE INC. | $34.61 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311803 | CMS |
| ABBVIE INC. | $19.47 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311805 | CMS |
| ABBVIE INC. | $20.09 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311807 | CMS |
| ABBVIE INC. | $28.42 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311809 | CMS |
| ABBVIE INC. | $17.52 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311811 | CMS |
| ABBVIE INC. | $26.67 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311813 | CMS |
| ABBVIE INC. | $21.18 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311815 | CMS |
| ABBVIE INC. | $28.28 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311817 | CMS |
| ABBVIE INC. | $18.09 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311819 | CMS |
| ABBVIE INC. | $15.66 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311821 | CMS |
| ABBVIE INC. | $6.30 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311823 | CMS |
| ABBVIE INC. | $25.88 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311825 | CMS |
| ABBVIE INC. | $29.22 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311827 | CMS |
| ABBVIE INC. | $24.23 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311829 | CMS |
| ABBVIE INC. | $31.10 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311831 | CMS |
| ABBVIE INC. | $22.43 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311833 | CMS |
| ABBVIE INC. | $14.31 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311835 | CMS |
| Acorda Therapeutics, Inc | $28.34 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142349558 | CMS |
| Alexion Pharmaceuticals, Inc. | $19.54 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093976531 | CMS |
| Amgen Inc. | $22.91 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116202357 | CMS |
| BANNER LIFE SCIENCES, LLC | $22.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147029577 | CMS |
| Neurocrine Biosciences, Inc. | $37.18 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150816842 | CMS |
| Neurocrine Biosciences, Inc. | $36.41 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150817684 | CMS |
| Novartis Pharmaceuticals Corporation | $21.26 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087430740 | CMS |
| Sumitomo Pharma America, Inc. | $23.91 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148933702 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.05 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137695192 | CMS |
| Teva Pharmaceuticals USA, Inc. | $29.50 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151572471 | CMS |
| UCB, Inc. | $37.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143425799 | CMS |
| UCB, Inc. | $25.90 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143425803 | CMS |
| UCB, Inc. | $38.52 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143425807 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.